- What is Pieris' stock symbol?
Our stock is traded on the NASDAQ Capital Market under the symbol PIRS.
- Can I buy stock directly from Pieris?
No, you will need to contact a licensed stockbroker or use an online trading account.
- How can I buy stock in Pieris?
Through a licensed stockbroker or by using an online trading account.
- How do I change the address on my shareholder account?
Through your brokerage account or by contacting our transfer agent.
- When was Pieris incorporated?
August 2000
- When did Pieris become a public company?
December 17, 2014
- Where is Pieris located?
Corporate Headquarters
Pieris Pharmaceuticals, Inc.
225 Franklin St., Floor 26
Boston, MA 02110
USAMunich site
Pieris Pharmaceuticals GmbH
Zeppelinstrasse 3
85399 Hallbergmoos
Germany- When is Pieris' fiscal year end?
December 31st
- Who is Pieris' transfer agent?
Computershare
P.O. Box 43006
Providence RI 02940-3078
T: 1- 877-373-6374 (US, Canada, Puerto Rico) or
1-781-575-3100 (non-US)
www.computershare.com/investor
web.queries@computershare.comCourier Delivery
150 Royall St.
Suite 101
Canton, MA 02021Shareholder Online Inquiries
https://www-us.computershare.com/investor/Contact- Who are Pieris' independent auditors?
Ernst & Young LLP
- Who is Pieris' outside legal counsel?
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, MA 02111
T: 617-542-6000- Whom can I contact for general information about Pieris?
info@pieris.com
In December 2024, Pieris Pharmaceuticals merged with Palvella Therapeutics, Inc. Palvella Therapeutics (Nasdaq: PVLA), is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. For more information about the Company and updates, please visit www.palvellatx.com or follow us on LinkedIn.